Regenerx Looks To Boost Liquidity Via Offering (RGN)
REGENERX BIOPHARMACEUTICALS, INC. (AMEX: RGN) filed for a secondary offering late yesterday to sell some $60 million in a secondary offering of stock and warrants. Its fully diluted market cap on last look was…